Small-cap stocks have quietly delivered their strongest quarter in four years, with the Russell 2000 index rising 12.4% in the third quarter. T ...
Wall Street cooled off on Tuesday after hitting new record highs yesterday, with investors weighing the fallout of the government shutdown against hopes for AI and strong corporate earnings ahead. ...
Staar Surgical has moved into the spotlight following the announcement of a proposed all-cash merger with Alcon at $28 per share, representing a 51% premium to its pre-deal stock price. ...
Shares of Advanced Micro Devices (AMD) soared sky-high on Monday after the chipmaker revealed a game-changing partnership with OpenAI that cements its role as a key rival to Nvidia in ...
US stocks were mixed on Monday as the federal government shutdown carried over into another week, but the AI trade stole the spotlight ...
EVgo eyes acquisitions amid EV headwinds, leveraging strong financing and falling CapEx to consolidate weaker peers. Can its inorganic growth unlock shareholder value before 30C credit expiry? ...
Bitcoin rose to near record highs this week as the U.S. government shutdown fueled demand for alternative assets. ...
TreeHouse Foods surged 14% on buyout buzz as Investindustrial eyes a ~$3B take-private. The small-cap food processor, focused on margins and core categories, draws strong investor interest in staples. ...
U.S. stocks rose on Friday, with the Dow Jones Industrial Average hitting 47,000 for the first time, as investors shrugged off a government shutdown and the delay of the September ...
Zevra Therapeutics jumped on renewed takeover chatter after a Betaville alert linked Collegium to a stalled bid. Strong MIPLYFFA growth, cash from voucher sale, & rare-disease pipeline fuel the buzz. ...
SiriusPoint sells ArmadaCare to Ambac for $250M, advancing its specialty focus. Ambac gains a growth foothold in health benefits, with the deal expected to add $220–$230M in pre-tax gains. ...
Harrow Inc. targets Melt Pharma buyout to expand sedation portfolio with MELT-300, a sublingual non-IV sedative, aiming for U.S. launch and global partnerships while diversifying beyond ophthalmics. ...